BEIJING, April 19 (TMTPOST) – Beijing Changfeng Hospital Co., Ltd. (870890.OC) was suspended from shares trading because of a failure to apply for suspension after a serious risk event, according to the National Equities Exchange and Quotations’ (NEEQ) announcement this morning.

A fire broke out at the inpatient department of the hospital on Tuesday, leading to a death toll of 29 by Wednesday. The injuries were mainly caused by smoke choking, instead of fire burns. Preliminary investigations suggest that the fire outbreak might be caused by construction work.

Following the event, CSC Financial Co., Ltd. issued a risk warning notice this morning, stating that the fire at the hospital had resulted in significant casualties and property losses. The exact extent of the losses is yet to be determined, but it is expected to have a negative impact on the hospital’s operations. The brokerage company is closely monitoring the situation and will comply with the relevant provisions to supervise the hospital’s information disclosure obligations. At the time of the announcement, the company had not been able to contact the company’s personnel. Investors are advised to be vigilant about potential investment risks.

Changfeng Hospital was listed on the NEEQ in 2017 as its first listed hospital company in the field of hemangioma. Due to the absence of a continuous bidding mechanism, trading in the hospital’s shares is largely inactive, with most transactions conducted through auction bidding and market making, as well as bulk trading channels for eligible transactions. As of December 2, 2021, the hospital’s trading price was 7 yuan per share, and its market value stood at 1.02 billion yuan, with a total transaction amount of 9.25 million yuan. However, no further transactions have been recorded since then. The most recent block trade occurred on November 26, 2021, with a transaction price of 2.45 yuan per share and a transaction amount of 1 million yuan, resulting in a closing discount of -30%.

The hospital’s financial performance has been underwhelming in recent years. In the first half of 2022, it recorded an operating revenue of approximately 253 million yuan, representing a 5.12% year-on-year decline. The net loss attributable to shareholders of the listed company widened to about 32.64 million yuan, while its total liabilities reached 462 million yuan. This followed two consecutive years of losses in 2021 and 2020, with net losses attributable to shareholders of the listed company amounting to 28.89 million and 37.29 million respectively.

According to the 2022 semi-annual report, Shenzhen Qinghong Investment Holding Co., Ltd. is the largest shareholder of the hospital, holding 48.11% of the shares. Beijing Yanglan Investment Management Center (Limited Partnership) is the second largest shareholder with 10.77% of the shares. Both are effectively controlled by natural person Wang Wenjie. The third to fifth largest shareholders of the hospital are all natural persons: Zhu Liwei, Wang Wenjie, and Meng Si, holding 9.89%, 7.03%, and 5.13% respectively. Wang Wenjie, born in 1969, is the founder, chairman, and general manager of the hospital.

The hospital announced earlier this month its plan to sell equity in two subsidiaries, with 100% of its equity in Changsha Xiangcheng Rehabilitation Hospital Co, Ltd. to be sold for 15 million yuan, and 51% of its equity in Guangzhou Changfeng Hospital Co, Ltd. to be sold for 5.35 million yuan. The hospital postponed its 2022 annual report disclosure to April 27 to ensure accuracy and content integrity.

本文内容来源：钛媒体英文站